-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KqYoQ3GAQToBC1kn77uggiCc+Wx5kRSHTxOJTOJ4p+3PdsK/Dylur6CEW+Mk7QMY nuZAU+Fx537hpkrTFG9qoQ== 0001104659-11-010100.txt : 20110225 0001104659-11-010100.hdr.sgml : 20110225 20110225104839 ACCESSION NUMBER: 0001104659-11-010100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110225 FILED AS OF DATE: 20110225 DATE AS OF CHANGE: 20110225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS AG CENTRAL INDEX KEY: 0001114448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 11638912 BUSINESS ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND STATE: V8 ZIP: CH 4056 MAIL ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND ZIP: CH 4056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDENIX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001093649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450478605 BUSINESS ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-9800 MAIL ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: NOVIRIO PHARMACEUTICALS LTD DATE OF NAME CHANGE: 19990820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS PHARMA AG CENTRAL INDEX KEY: 0001030617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 11638911 BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 BUSINESS PHONE: 212-830-2474 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 FORMER NAME: FORMER CONFORMED NAME: NOVARTIS INC DATE OF NAME CHANGE: 19970114 4 1 a4.xml 4 X0303 4 2011-02-25 0 0001093649 IDENIX PHARMACEUTICALS INC IDIX 0001114448 NOVARTIS AG LICHSTRASSE 35 BASEL V8 CH 4002 SWITZERLAND 0 0 0 1 Indirect 10% Owner 0001030617 NOVARTIS PHARMA AG LICHSTRASSE 35 BASEL V8 CH 4002 SWITZERLAND 0 0 1 0 Common Stock 2011-02-25 4 P 0 17270 2.41 A 31395754 I See footnote Common Stock 2011-02-25 4 P 0 897 2.96 A 31396651 I See footnote Common Stock 2011-02-25 4 P 0 860 3.79 A 31397551 I See footnote Common Stock 2011-02-25 4 P 0 1760 3.88 A 31399271 I See footnote Common Stock 2011-02-25 4 P 0 206 5.11 A 31399477 I See footnote These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG, Novartis AG is an indirect beneficial owner of these securities. See attachment. Ramon Zapata-Gomez Head Finance Operations 2011-02-25 Felix Eichhorn authorized signatory 2011-02-25 -----END PRIVACY-ENHANCED MESSAGE-----